About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte
transgene insertion 10, TaconicArtemis
MGI:4417910
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Gt(ROSA)26Sortm1(Thy1-FBXL2)Wata/Gt(ROSA)26Sor+
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/0
involves: C57BL/6 * C57BL/6N * CBA MGI:5318569
tg2
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte involves: C57BL/6 * CBA MGI:4417912
tg3
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/0 involves: C57BL/6 * CBA MGI:4417913


Genotype
MGI:5318569
cx1
Allelic
Composition
Gt(ROSA)26Sortm1(Thy1-FBXL2)Wata/Gt(ROSA)26Sor+
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/0
Genetic
Background
involves: C57BL/6 * C57BL/6N * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Thy1-FBXL2)Wata mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• mice exhibit a reduction in amyloid plaques compared with Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte mice

homeostasis/metabolism
• mice exhibit a reduction in amyloid plaques compared with Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte mice




Genotype
MGI:4417912
tg2
Allelic
Composition
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype

Amyloid pathology and glial inflammation in hemizygous and homozygous Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte mouse brain

mortality/aging
• mice exhibit 85% survival
• 2 of 13 mice die before 12 months of age

nervous system
• as early as 3 to 5 months, mice exhibit plaques in the anterior neocortex and subiculum unlike wild-type mice
• mmice exhibit plaque accumulation in the posterior neocortex, CA1 through 4 regions of the hippocampus, amygdala and related limbic structures, and thalamus unlike in wild-type mice
• plaques also accumulate in the olfactory bulb, colliculi, brainstem, and the striatum
• at 8 months, large plaques develop in the thalamus compared with wild-type mice
• older mice develop diffuse deposits of beta-amyloid
• plaque size increases with age
• dense-core plaques are encompassed by a sphere of early-dystrophic, swollen neurites with ubiquitin accumulation unlike in wild-type mice

behavior/neurological
• at 12 months, mice exhibit a deficit in episodic memory with reduced exploration of a novel object compared with wild-type mice
• at 12 months, mice exhibit reduced performance in a Morris water maze test compared with wild-type mice
• at 12 months, mice from the cross-sectional cohort display poor memory in a Morris water maze compared with wild-type mice
• at 4 months but not in older mice, anxiety related behaviors are increased with mice spending less time in the center of an open field and entering the open sector of a zero maze compared with wild-type mice
• at 12 months, mice exhibit a deficit in episodic memory with reduced exploration of a novel object compared with wild-type mice
• at 4 months but not in older mice, exploratory activity is decreased in a Y maze compared with wild-type mice

immune system

hematopoietic system

homeostasis/metabolism
• as early as 3 to 5 months, mice exhibit plaques in the anterior neocortex and subiculum unlike wild-type mice
• mmice exhibit plaque accumulation in the posterior neocortex, CA1 through 4 regions of the hippocampus, amygdala and related limbic structures, and thalamus unlike in wild-type mice
• plaques also accumulate in the olfactory bulb, colliculi, brainstem, and the striatum
• at 8 months, large plaques develop in the thalamus compared with wild-type mice
• older mice develop diffuse deposits of beta-amyloid
• plaque size increases with age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:155410




Genotype
MGI:4417913
tg3
Allelic
Composition
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype

Amyloid pathology and glial inflammation in hemizygous and homozygous Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte mouse brain

nervous system
• as early as 3 to 5 months, mice exhibit plaques in the anterior neocortex and subiculum unlike wild-type mice
• mice exhibit plaque accumulation in the posterior neocortex, CA1 through 4 regions of the hippocampus, amygdala, and related limbic structures unlike in wild-type mice
• at 10 to 11 months, large plaques develop in the thalamus unlike in wild-type mice

homeostasis/metabolism
• as early as 3 to 5 months, mice exhibit plaques in the anterior neocortex and subiculum unlike wild-type mice
• mice exhibit plaque accumulation in the posterior neocortex, CA1 through 4 regions of the hippocampus, amygdala, and related limbic structures unlike in wild-type mice
• at 10 to 11 months, large plaques develop in the thalamus unlike in wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory